Search Results 391-400 of 12499 for alp

1. The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

   Subjects with aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT), alkaline phosphatase (ALP) or total ...

2. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   Alkaline phosphatase ≤ 5 x ULN; Total bilirubin ≤ 1.5 x ULN (patients with known Gilbert disease should contact the study PI); Not pregnant or nursing ...

3. A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   Liver function tests: alanine aminotransferase (ALT) <2x upper limit of normal (ULN); alkaline phosphatase <=1.5xULN; bilirubin <=1.5xULN (isolated ...

4. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

   ... Alkaline phosphatase ≤2.5 x ULN; Negative Hepatitis B and Hepatitis C testing;; QTc interval ≤450ms. Exclusion Criteria: Radiation within 14 days of study ...

5. A Study to Evaluate the Safety and Effectiveness of Hypofractionation Proton Beam Therapy in Patients with Clinically Localized, Intermediate, or High Risk Prostate Cancer

   Total bilirubin, aspartate aminotransferase, alkaline phosphatase, and serum creatinine: < 2 x upper normal limit; Signed informed consent. Exclusion Criteria.

6. A Study of the Effect of Vedolizumab in Conjunction with Structured Semi-Vegetarian Diet on the Treatment of Ulcerative Colitis - Mayo Clinic

   ... Alkaline phosphatase >3 × ULN, g) Serum creatinine >2 × ULN; Antibiotic use within past 14 days; Probiotics use within past 7 days. Participating Mayo Clinic ...

7. Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer - Mayo Clinic

   - Alkaline phosphatase ≤ 2.5 x ULN or alkaline phosphatase ≤ 5 x ULN if elevations are due to liver metastases. - Electrocardiogram (EKG) completed ≤ 15 ...

8. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

   Alkaline phosphatase (AP) ≤ 2.5 x ULN; Aspartate transaminase (AST) or alanine transaminase (ALT) ≤3 x ULN, unless considered due to organ leukemic ...

9. Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim 2) - Mayo Clinic

   ... alkaline phosphatase or bilirubin > 2x normal); Serum sodium of < 125 mEq/dL or > 150 mEq/dL; Serum potassium of < 3.2 mEq/dL or > 5.9 mEq/dL; Prior diagnosis ...

10. A Study to Assess the Effectiveness and Safety of UGN-102 as a Primary Chemoablation Agent in Patients with Low Grade Non-Muscle-Invasive Bladder Cancer (LG NMIBC) at Intermediate Risk of Recurrence - Mayo Clinic

    ... ALP ≤2.5 × ULN, and Estimated glomerular filtration rate (eGFR) ≥30 mL/min. Has no evidence of active urinary tract infection (UTI) at Screening and ...